What is the current stock price of FibroBiologics, Inc. Common Stock (FBLG)?

As of the latest market data, FibroBiologics, Inc. Common Stock (FBLG) is trading at $1.12. The stock has seen a gain of 5.66% today.

Does FibroBiologics, Inc. Common Stock (FBLG) pay a dividend?

Based on current data, FibroBiologics, Inc. Common Stock does not have a confirmed active dividend policy.

What is the market cap of FibroBiologics, Inc. Common Stock?

The current market capitalization of FibroBiologics, Inc. Common Stock (FBLG) is approximately unavailable.

FBLG

FibroBiologics, Inc. Common Stock·Healthcare

1.12

5.660%(+0.06)

Close Price

1.14

1.786%(+0.02)

After Hours

Last Updated: — ET

52W L: $0.9552W H: $19.80

Company Profile

FibroBiologics, Inc., a clinical-stage cell therapy company, develops and commercializes fibroblast-based therapies in the United States. It is developing CybroCell, for the treatment of degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for wound healing. The company is also on the early-stage research of CYTER915, which is designed to regenerate or reinvigorate production of the thymus and/or spleen; CYPS317, for the treatment of psoriasis; and TCB190 to treat certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2024-02-01

Beta

1.10

Websitewww.fibrobiologics.com↗